chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shoulder pain; Hand pain; Arm pain; Knee pain; Foot pain; Stiffness; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 01Jun2021 at 00:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoarthritis which is ongoing and also asthma, high cholesterol, osteoarthritis, high blood pressure (BPH), COVID-19 and known allergy of shellfish.  Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA), morniflumate (FLOMAX) and acetylsalicylic acid (ASPIRIN); from an unknown start date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 10May2021 at 00:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. On 22Jun2021 the patient experienced shoulder pain, hand pain, arm pain, knee pain, foot pain and stiffness.  It was far more significant than any arthritis pain prior to that. The patient's osteoarthritis was in remission with no pain. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shoulder pain, hand pain, arm pain, knee pain, foot pain and stiffness were not recovered at the time of this report.
Recurring Herpes Zoster/ occurs on the mandibular branch of his face, no other location/ His HZ was "never severe, just recurrent"; This spontaneous report was received from a physician via company representative concerning a 55-year-old male patient. The patient's medical history included natural varicella and it was reported that the patient presented herpes zoster every time he ran a marathon; the reporter confirmed that the patient had been on valacyclovir hydrochloride (VALTREX) prophylaxis for years and it was doing fine. The patient's concurrent conditions were not provided.  On an unknown date, approximately in 2010, the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (Strength, dosage regimen, lot number and expiration date were not provided) due to his recurring herpes zoster episodes.   On an unknown date, approximately 3 years post-vaccination, the patient experienced Herpes Zoster on the mandibular branch of his face, no other location. Per the physician PCR testing was not performed; since it was assumed a wild type virus. The reporter did not considered the herpes zoster post vaccination to be an adverse event.   At the time of the report it was unknown if the patient had recovered from the herpes zoster reactivation. The causal relationship between zoster vaccine live(ZOSTAVAX) and the event was not reported.
chills; fever; diarrhea; vomiting; This is a spontaneous report from a contactable consumer. A 90-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced chills, fever, diarrhea and vomiting. The outcome was unknown for the reported events.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a consumer and described the occurrence of seizures in a 4 month old male subject who was vaccinated with Pediarix for prophylaxis. The reporter is the mother of the subject and a sales representative. A physician or other health care professional has not verified this report. The subjects medical history included premature birth. There were no concurrent medications. The subject no adverse events following receipt of prior immunizations. On 11 July 2006 the subject received 2nd dose of Pediarix. On 11 July 2006, the subject received an unspecified dose of Prevnar. On 12 July 2006, 1 day after vaccination with Pediarix, the subject experienced three seizures and stopped breathing four times. The subject was transported by ambulance to an emergency room. During transport to the emergency room, the subject required resuscitation. The reporter considered the events to be life threatening and to require clinically significant intervention (OMIC). The events resolved on 12 July 2006.
The patient presented to the Emergency Department with cough for 3 days, nausea, vomiting, fatigue, decreased appetite, and chest congestion. Upon admission on 03/25/21, the patient tested positive for COVID-19. The patient received levofloxacin followed by ceftriaxone/azithromycin, dexamethasone, remdesivir, and convalescent plasma.
Patient came for her booster dose and mentioned that 3 days after receiving her 2nd dose she developed a rash on her abdomen. She went to the Dr. and was given a topical cream to teat it. The rash resolved within a week. I suggested for her to have benadryl on hand in case the rash was vaccine related and in case she experienced symptoms of allergic reaction.
The day after the vaccine i notice my body look puffy, bloated, and within 2 weeks, I had put on 5lbs (nothing changed, I work out a lot and eat healthily. This has never happened). I have now gone up two full clothing sizes and symptoms are NOT improving at all. I accidentally got the vaccine a month early, and thought i was getting a 1/2 dose but had a full 3rd dose. I was very fatigued for about a week, but that was expected.
This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE PAIN (burning sensation from his arm to his neck ~ 45 minutes after getting the vaccine) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, the patient experienced VACCINATION SITE PAIN (burning sensation from his arm to his neck ~ 45 minutes after getting the vaccine). At the time of the report, VACCINATION SITE PAIN (burning sensation from his arm to his neck ~ 45 minutes after getting the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.  The vaccine was given at the Pharmacist's clinic.
This case was reported by a healthcare professional and described the occurrence of heat sensation in arm in a subject of unspecified age and gender who was vaccinated with TWINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of TWINRIX (unknown). On an unspecified time after vaccination with TWINRIX, the subject experienced heat sensation in arm. At the time of reporting the outcome of the event was unspecified. A traveling nurse reported that she was aware of several subjects who after being vaccinated with TWINRIX (pre-filled syringe) experienced heat down the arm which did not last long.
significant joint pain that began the day after the vaccine, and has worsened, along with painful, erythematous, swollen nodules noted to palmar aspects of bilateral hands/wrists -brief improvement after a prednisone taper that was started approximately a month after symptoms presented, had autoimmune work-up that was negative, and his symptoms returned approximately a week after the prednisone taper.  Seen again on 3/30/21 with worsening nodules and joint pain to her bilateral arms and hands.  Pending dermatology and likely rheumatology evaluation
Upper respiratory virus, developed Guillain Barre.  Numbness and tingling and weakness in all four extremities.
After being vaccinated that evening, the pt experienced swollen lymph glands and soreness under her left arm and arm pit. On 11/01/2000 the pt recovered.
ITCHING; TINGLING IN SKIN; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 21-MAR-2021 for prophylactic vaccination on right arm. No concomitant medications were reported. On an unspecified date, the subject experienced itching, and tingling in skin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the itching and tingling in skin was not reported. This report was non-serious.
Anaphylaxis. Hives, anterior/posterior throat swelling, shortness of breath. Resolved with epinephrine drip, receiving three epinephrine injections and Benadryl from EMS. Likely will be kept for observation given epi drip.
pharmacist on duty administered without "dilute prior to use" for pfizer covid vaccine (age 5-11).
Large area of redness and swelling & temp on back portion of arm developed within 24 hours of injection. Also an area of hardness in center.
injection site redness; swelling / injection site; This case was reported by a consumer via interactive digital media and described the occurrence of injection site erythema in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site erythema and injection site swelling were unknown.   It was unknown if the reporter considered the injection site erythema and injection site swelling to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was selected as per the vaccine indication. The patient asked what should do for swelling and injection site redness from Shingrix.
fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 80-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Oct2022 as dose number unknown, single (Lot number: GH9694) at the age of 79 years for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: HYDRALAZINE; OMEGA 3 FATTY ACID; ATORVASTATIN. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "fever". Therapeutic measures were taken as a result of pyrexia.  Additional information: Consumer stated Atorvastatin is a statin for cholesterol and the doctor said he don't have a high cholesterol but they have given that because of his age. For dose and frequency for Hydralazine, consumer stated, "Biggest dose in the morning as 320 mg then, 50 mg 5-6 hours later and again 50 mg 5-6 hours later. Consumer stated about treatment that, the only thing he took was Tylenol, he did not know what else to take.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300314876 same patient, different event/ drug;
Product storage error; dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) and PRODUCT STORAGE ERROR (Product storage error) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that, there was a confusion between the expiration date printed in the carton the expiration date when the QR code was scanned.   The vial was initially refrigerated on 27-Nov-2021, the vial did not undergo any temperature excursion and patient did not experience any adverse events.  No treatment medications were reported.
I have experienced a sore left upper arm consistently since August 27 date of vaccine (it is now Nov. 10), sharp pain in left shoulder, burning discomfort below  left scapula.  I have taken ibuprofen, received massage therapy. I experience some relief from ibuprofen and somewhat from rolfing massage therapy
Rash throughout body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash throughout body) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash throughout body). At the time of the report, RASH (Rash throughout body) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
Fatigue for 2 and a half days.  Headache for 2 days Both started morning after vaccine.  Tightness in chest still lingering after one week when I take deep breaths. Need to take more deep breaths.
Swollen face, eyes, left side of neck and lymph nodes; erythema, swelling and pain of chin.
I also had severe reactions to the first injection on October 6, 2020.  Symptoms started both times about 3 hours after the injection. They are: Sore arm, fever 101, nausea, headache, diarrhea, body aches and chills. Lasted over 5 days.  In Oct 2020  I also received the flu vaccine which the dr and pharmacist blamed the reaction. However this second round was just the Shingrix and same reaction.
The patient became pale very shortly after the above vaccinations were administered. She became weak and limp and non-responsive for approximately 30 seconds. The patient began to slide off the exam table and she was safely placed supine on the exam table by her father and myself. Her pupils were dilated. The patient's pulse oximetry was 99-100% on room air. A blood glucose was 84 and her B/P was 12/64. 911 was activated. The patient became responsive and oriented. Her pupils were equal. The father, who is a paramedic, asked that the 911 call be cancelled, although the EMT's were in the clinic parking lot. Then, the patient's pupils began to dilate again and the patient became pale again. The EMT's were asked to access the patient.(cont'd)> next page:
little bit of a sore arm; redness on the site of the injection; arm was itchy; became more swollen; hardness; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (little bit of a sore arm), INJECTION SITE ERYTHEMA (redness on the site of the injection), INJECTION SITE PRURITUS (arm was itchy), INJECTION SITE SWELLING (became more swollen) and INJECTION SITE INDURATION (hardness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced INJECTION SITE PRURITUS (arm was itchy), INJECTION SITE SWELLING (became more swollen) and INJECTION SITE INDURATION (hardness). On an unknown date, the patient experienced PAIN IN EXTREMITY (little bit of a sore arm) and INJECTION SITE ERYTHEMA (redness on the site of the injection). At the time of the report, PAIN IN EXTREMITY (little bit of a sore arm) and INJECTION SITE ERYTHEMA (redness on the site of the injection) outcome was unknown and INJECTION SITE PRURITUS (arm was itchy), INJECTION SITE SWELLING (became more swollen) and INJECTION SITE INDURATION (hardness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Two days after getting the flu shot, I started to feel sick with flu like symptoms. On Saturday and Sunday (20 -21 October 07) I was weak and started a mild cough and spent the weekend resting.  For the next week, in the mornings I felt ok, but by early afternoon was weak, tired coughing, and ended up going home from work early on a number of days.  On the following weekend I was so sick I stayed in bed resting.  On 30 October, at about 0900 hrs the left side of my head started hurting so bad I called for an immediate doctor's appointment.  I went in at 1400 hrs.  I was examined by Dr. and she ordered a chest x-ray and prescribed a two week regiment of antibiotics to combat a sinus infection.  After about three days on the drugs I started to feel better but continued to be weak and tired and had a strong cough.  On 28 November, I went back to the doctor and was examined by Dr. who put me on a five day regiment of antibiotics, and ordered another chest x-ray to insure I did not have pneumonia.    As of today, 9 Dec 07, I feel almost normal.  I believe the treatment from my doctors to be excellent.  However, I believe my six plus week illness to be directly related to the flu shot I received.
Fever chills, pain at injection site Narrative: Per supervisor report: "received her 2nd Merderma injection on 5/10/2021 having symptoms of fever chills, and  pain at injection site."
The dose administered past the expiry date was their booster dose, administered on 12Nov2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The dose administered past the expiry date was their booster dose, administered on 12Nov2021) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A, 025A21A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The dose administered past the expiry date was their booster dose, administered on 12Nov2021). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (The dose administered past the expiry date was their booster dose, administered on 12Nov2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported No treatment medication was reported
This spontaneous report as received from an office manager who reported confusion with the direction for the preparation of M-M-R II. The office manager reported that as the prescribing information states, the dose of M-M-R II should be 0.5mL, but that that supplied diluent is 0.7mL. Since the prescribing information states to withdraw the entire contents of the diluent to reconstitute, then to withdraw the entire contents of the reconstituted mixture, this would create a possibility of 0.2mL overage. The office manager reported that this causes confusion. No adverse effects reported. PQC filed in 382484. Feedback forward in 382816. Additional information is not expected as there was no consent to contact reporter.
pt recv vax approx 330PM 3JAN96 &  5PM began screaming whenever moved then screamed cont for 3hr;about 9PM went to ER-was given DPH;settled down very quickly-OK by next day
I don't know whether or not there is a connection, but the timing of my symptoms is suspicious. Tuesday, Jan 17th at pharmacy at 1:00 pm, I got my 1st singles shot. About an hour and a half later I suddenly developed a very red, very sore spot on the surface of my tongue (~½ cm in diameter), and also on my lower lip (left side in both cases). The soreness continued all day. By 10:30 pm that evening I additionally noticed 2 pustules (or fluid-filled bubbles) on the sore spot on my lip, though the area was less red. The red spot on my tongue was still present, but not quite as sore. By the next day, the spot on my tongue was still red, but much less sore. Lip spot less red, less sore. By Friday (3 days after the shot) the spot on my tongue was no longer red, although a dense area on that spot remained, with some tenderness upon palpation; the spot on my lip resolved. There was nothing else that might have caused those spots, as I hadn't bitten my tongue or lip, or eaten anything that would have had that effect, so I suspect a link to the vaccine. I'm curious whether anyone else experienced a similar reaction or if this is just an anomaly.
Erythema, induration, and pain at the site of injection (Right Deltoid) that developed the following evening that patient got the vaccine (patient unclear exactly what time it began that evening). Erythema/Induration was about 15cm x 18cm.
Dec. 22, 2008, family medicine--Got shingles vaccine around 2:00pm in my upper right arm; given by medical assistant II.  She had taken my temperature, which was 98 (normal for me).  Saw P.A. before I got the shot, but she was not in the room when it was given.  I was handed the a vaccine information statement after the shot was given.  I took on TYLENOL 500 mg capsule preventatively.  Within 1-1/2 hours, my right little toe, which had been broken in Aug. 2005, spontaneously began to hurt.  I had not bumped it, nor was I wearing tight shoes (I was wearing mules with lots of toe room), so that was odd, as it has bothered me before.  I had no arm pain that nite.  Dec. 23, 2003, When I took the bandaid off my arm in the morning, it was not red.  At noon (22 hours after getting the vaccine), I felt pain in my thigh bones--the same pain as when I was on Neupogen in 1997 during chemotherapy, but not as severe.  I was also very tired.  My temperature was 98.8, which is fever for me.  I called clinic and relayed was what going on;  the message came back that doctor was with a patient but said I should take TYLENOL and put a cool (not ice) compress on my arm it it hurt (I did both).  The arm had red blotches and was a bit itchy.  Blisters looked like they were trying to form, but didn't.  Slept all day;  by 8:00p.m. I felt much better.  Dec. 24, 2008, No fever, some bone pain in thighs.  Arm redness was 2 inches in diameter (I measured) and itchy & painful.  Dec. 25, 2008, Pain was down in bones;  arm redness down to 1/2 of Dec. 24 but still sore.  Pain lingered in my thigh bones until mid January.
Patient presented with platelet count of 1 and anemia.  ITP was diagnosis.  IVIG 50g IV x2, steroids (prednisone 60mg daily), and platelet transfusion given x2.